DKSH has entered into a partnership with Alvimedica to assist in distributing and managing logistics for Alvimedica’s products in Malaysia.
Petaling Jaya, May 16, 2024 – DKSH Business Unit Healthcare, a leading partner for companies seeking to grow their healthcare business in Asia and beyond, has successfully entered into a strategic partnership with Alvimedica, a global producer of unique medical devices, in Malaysia. DKSH will enhance the distribution of Alvimedica's distinctive products throughout Malaysia, harnessing the power of innovation to improve the quality of life.
This partnership aims to utilize DKSH Malaysia Healthcare’s specialized expertise in market expansion services to enhance the efficiency of the supply chain and facilitate seamless distribution of Alvimedica’s competitive and high-quality innovative products across various distribution channels, including private and public hospitals in Malaysia.
Chua Ruxuan, Country Manager at Alvimedica, commented: “We have selected DKSH Malaysia as our partner due to their comprehensive consignment service and proven track record in the medical devices segment. We believe in their ability to advance our mission of addressing current healthcare challenges and unmet patient needs. This strategic partnership underscores our shared objectives for growth and success. With the support of DKSH, we anticipate collaborative endeavors that will propel Alvimedica's continued success.”
Sandeep Tewari, Head Country Management and Vice President, Healthcare, DKSH Malaysia, added: “This partnership with Alvimedica symbolizes a joint commitment to innovation, growth, and delivering high-quality healthcare solutions to a wider audience. Our enthusiasm stems from the belief that, together with Alvimedica, we can reach new milestones and provide healthcare for all.”
About Alvimedica
Alvimedica is a global innovator in interventional medical devices, dedicated to developing and manufacturing high-quality products in endovascular and interventional cardiology. With manufacturing plants in Italy and Turkey, our mission is to improve patient outcomes through innovative technology. Our product range includes bare metal stents, guiding catheters, and balloon catheters in interventional cardiology, with exclusive polymer-free drug-eluting stents. In endovascular care, we offer solutions for various regions, including iliac, femoro-popliteal and below the knee regions. For more information, please visit www.alvimedica.com.
About DKSH
DKSH’s purpose is to enrich people’s lives. For almost 160 years, DKSH has been delivering growth for companies in Asia and beyond across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales ser-vices. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 29,040 specialists, generating net sales of CHF 11.1 billion in 2023. DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health, and over-the-counter products as well as medical devices. With around 8,140 specialists, the Business Unit generated net sales of CHF 5.6 billion in 2023. www.dksh.com/hec